Literature DB >> 23127757

Stem cell applications in regenerative medicine for neurological disorders.

Shih-Ping Liu1, Ru-Huei Fu, Shyh-Jer Huang, Yu-Chuen Huang, Shih-Yin Chen, Cheng-Hsuan Chang, Chia-Hui Liu, Chang-Hai Tsai, Woei-Cherng Shyu, Shinn-Zong Lin.   

Abstract

Stem cells are capable of self-renewal and differentiation into a wide range of cell types with multiple clinical and therapeutic applications. Stem cells are providing hope for many diseases that currently lack effective therapeutic methods, including stroke, amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease. Embryonic stem (ES) cells were originally targeted for differentiation into functional dopamine neurons for cell therapy. Today, induced pluripotent stem (iPS) cells are being tested for such purposes as generating functional dopamine neurons and treating a rat model of Parkinson's disease. In addition, neural stem cell and mesenchymal stem cells are also being used in neurodegenerative disorder therapies for stroke and Parkinson's disease. Although stem cell therapy is still in its infancy, it will likely become a powerful tool for many diseases that currently do not have effective therapeutic approaches. In this article, we discuss current research on the potential application of neural stem cells, mesenchymal stem cells, ES cells, and iPS cells to neurodegenerative disorders.

Entities:  

Mesh:

Year:  2012        PMID: 23127757     DOI: 10.3727/096368912X655145

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  11 in total

Review 1.  Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke.

Authors:  Yao-Hui Tang; Yuan-Yuan Ma; Zhi-Jun Zhang; Yong-Ting Wang; Guo-Yuan Yang
Journal:  CNS Neurosci Ther       Date:  2015-02-10       Impact factor: 5.243

2.  Distinct Effects of the Hippocampal Transplantation of Neural and Mesenchymal Stem Cells in a Transgenic Model of Alzheimer's Disease.

Authors:  Henrique C Campos; Deidiane Elisa Ribeiro; Debora Hashiguchi; Deborah Y Hukuda; Christiane Gimenes; Simone A A Romariz; Qing Ye; Yong Tang; Henning Ulrich; Beatriz Monteiro Longo
Journal:  Stem Cell Rev Rep       Date:  2022-01-08       Impact factor: 5.739

3.  Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.

Authors:  Wenbin Liao; Victor Pham; Linan Liu; Milad Riazifar; Egest J Pone; Shirley Xian Zhang; Fengxia Ma; Mengrou Lu; Craig M Walsh; Weian Zhao
Journal:  Biomaterials       Date:  2015-11-10       Impact factor: 12.479

4.  Transplantation of Induced Pluripotent Stem Cells Alleviates Cerebral Inflammation and Neural Damage in Hemorrhagic Stroke.

Authors:  Jie Qin; Xun Ma; Haiyun Qi; Bo Song; Yanlin Wang; Xuejun Wen; Qing Mei Wang; Shilei Sun; Yusheng Li; Rui Zhang; Xinjing Liu; Haiman Hou; Guangming Gong; Yuming Xu
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

Review 5.  Exploiting Heparan Sulfate Proteoglycans in Human Neurogenesis-Controlling Lineage Specification and Fate.

Authors:  Chieh Yu; Lyn R Griffiths; Larisa M Haupt
Journal:  Front Integr Neurosci       Date:  2017-10-17

6.  Introduction to the Special Issue on Stem Cells and Regenerative Medicine.

Authors:  Qinan Yin
Journal:  Eur J Histochem       Date:  2020-06-19       Impact factor: 3.188

Review 7.  Stem cell therapy in autism: recent insights.

Authors:  Dario Siniscalco; Suresh Kannan; Neomar Semprún-Hernández; Adrien A Eshraghi; Anna Lisa Brigida; Nicola Antonucci
Journal:  Stem Cells Cloning       Date:  2018-10-23

8.  Atlas of regulated target genes of transcription factors (ART-TF) in human ES cells.

Authors:  Alexei A Sharov; Yuhki Nakatake; Weidong Wang
Journal:  BMC Bioinformatics       Date:  2022-09-16       Impact factor: 3.307

9.  Therapeutic Efficacy of Mesenchymal Stem Cells and Mesenchymal Stem Cells-derived Neural Progenitors in Experimental Autoimmune Encephalomyelitis.

Authors:  Fatemeh Nasri; Maryam-Sadat Mohtasebi; Esmaeil Hashemi; Maryam Zarrabi; Nasser Gholijani; Eskandar Kamali Sarvestani
Journal:  Int J Stem Cells       Date:  2018-05-30       Impact factor: 2.500

Review 10.  Stem Cell Applications for Treatment of Cancer and Autoimmune Diseases: Its Promises, Obstacles, and Future Perspectives.

Authors:  Yousef M Hawsawi; Faisal Al-Zahrani; Charalampos Harris Mavromatis; Mohammed A Baghdadi; Shalini Saggu; Atif Abdulwahab A Oyouni
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.